Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection

Neuroscience Letters

Volumn 465, Issue 3, 2009, Pages 242-247

  Richards, Natalie ^a   Wayman, Chris ^a   Allers, Kelly A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Apomorphine; Dopamine receptor stimulation; Local field potential; Sexual behaviour

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ALPHA RHYTHM; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL POPULATION; CONTROLLED STUDY; DELTA RHYTHM; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; MALE; NERVE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; THETA RHYTHM;

ACTION POTENTIALS; ANIMALS; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PENILE ERECTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70349784877     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.08.078     Document Type: Article

References (19)

1. Argiolas A., Melis M.R., Mauri A., and Gessa G.L. Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not by ACTH in rats. Brain Res. 421 (1987) 349-352
2. Becker A.J., Uckert S., Ness B.O., Stief C.G., Scheller F., Knapp W.H., and Jonas U. Systemic and cavernous plasma levels of vasopressin in healthy males during different functional conditions of the penis. Urol. Res. 31 (2003) 66-69
3. Boer K., and Nolten J.W. Hypothalamic paraventricular unit activity during labour in the rat. J. Endocrinol. 76 (1978) 155-163
4. Brack K.E., Watkins N., Pyner S., and Coote J.H. A physiological role for nitric oxide in the centrally mediated sympathetic and somatomotor ejaculatory response in anesthetized male Wistar rats. Neuroscience 150 (2007) 487-497
5. Caruso S., Agnello C., Intelisano G., Farina M., Di Mari L., and Cianci A. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology 63 (2004) 955-959
6. Chang A.Y.W., Chan J.Y.H., and Chan S.H.H. Participation of hippocampal formation in negative feedback inhibition of penile erection in the rat. Brain Res. 788 (1998) 160-168
7. Chen K.K., Chan J.Y., and Chang L.S. Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat. J. Urol. 162 (1999) 237-242
8. Feifer A., and Carrier S. Pharmacotherapy for erectile dysfunction. Expert Opin. Investig. Drugs 17 (2008) 679-690
9. Gulia K.K., Jodo E., Kawauchi A., Miki T., Kayama Y., Mallick H.N., and Koyama Y. The septal area, site for the central regulation of penile erection during waking and rapid eye movement sleep in rats: a stimulation study. Neuroscience 156 (2008) 1064-1073
10. Heaton J.P., Morales A., Adams M.A., Johnston B., and el-Rashidy R. Recovery of erectile function by the oral administration of apomorphine. Urology 45 (1995) 200-206
11. Hellstrom W.J. Clinical applications of centrally acting agents in male sexual dysfunction. Int. J. Impot. Res. 20 Suppl 1 (2008) S17-23
12. Kiss J.Z. Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus. Brain Res. Bull. 20 (1988) 699-708
13. McKenna K.E. Some proposals regarding the organization of the central nervous system control of penile erection. Neurosci. Biobehav. Rev. 24 (2000) 535-540
14. Melis M.R., Argiolas A., and Gessa G.L. Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system. Eur. J. Pharmacol. 164 (1989) 565-570
15. Montorsi F., Perani D., Anchisi D., Salonia A., Scifo P., Rigiroli P., Zanoni M., Heaton J.P., Rigatti P., and Fazio F. Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction. Int. J. Impot. Res. 15 (2003) 203-209
16. Patel M.V., Kolasa T., Mortell K., Matulenko M.A., Hakeem A.A., Rohde J.J., Nelson S.L., Cowart M.D., Nakane M., Miller L.N., Uchic M.E., Terranova M.A., El-Kouhen O.F., Donnelly-Roberts D.L., Namovic M.T., Hollingsworth P.R., Chang R., Martino B.R., Wetter J.M., Marsh K.C., Martin R., Darbyshire J.F., Gintant G., Hsieh G.C., Moreland R.B., Sullivan J.P., Brioni J.D., and Stewart A.O. Discovery of 3-methyl-N-(1-oxy-3′,4′,5′,6′-tetrahydro-2′H-[2,4′-bipyridine]-1′-ylmethyl)benzam ide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. J. Med. Chem. 49 (2006) 7450-7465
17. Pedersen C.A., and Boccia M.L. Vasopressin interactions with oxytocin in the control of female sexual behavior. Neuroscience 139 (2006) 843-851
18. Poulain D.A., Wakerley J.B., and Dyball R.E. Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones. Proc. R. Soc. Lond. B: Biol. Sci. 196 (1977) 367-384
19. Succu S., Sanna F., Melis T., Boi A., Argiolas A., and Melis M.R. Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: involvement of central oxytocin. Neuropharmacology 52 (2007) 1034-1043